news
SOCIETY NEWS
Karger SFN journal self-nominations of reviewers initiative.
Follow the link below for complete information on this important opportunity!
Do you want to perfect your own author’s skills and stay connected with the latest trends and future developments in your research field? Apply now to become a reviewer for the Journal Stereotactic and Functional Neurosurgery.
To increase and diversify the profile of reviewers of scientific articles, Karger is now enabling self-nominations of peer-reviewers.
Researchers interested in working as reviewers can now register by filling out the form on the page: karger.com/Resources/engage-with-us-anad-get-recognized/reviewer-self-nomination.
For registration it is necessary to inform personal data, institutional affiliations, academic and professional background, areas of expertise, as well as editorial experiences.
Karger and Stereotactic and Functional Neurosurgery are supportive of a thoughtful and inclusive peer review process and encourage the provision of fair and constructive feedback by the reviewers to the authors. An inclusive peer review may also fill gaps both in expertise and availability of reviewers. With this in mind, we offer our reviewers a clear set of guidelines on how to peer review. The guidelines cover topic such as criteria for evaluating a manuscript, critical factors in each section of a manuscript, ethical aspects, and guidance about the submission of one’s review report, among others.
Further Stereotactic and Functional Neurosurgery offers to their reviewers a reviewer certificate and free access to e-learning courses on how to perform scientific peer review (code is distributed with your first invitation).
Interested? Send your application via this form and make sure to select Stereotactic and Functional Neurosurgery from the drop down menu of Journals.
Learn more about Karger’s initiatives on “Engaging and Rewarding Researchers” in their different roles and career stages.
Ten years after a clinical report of DBS for refractory OCD (The Lancet 1999, 354:1526), the U.S. Food and Drug Administration (FDA) approved deep brain stimulation (DBS) for treatment-refractory obsessive-compulsive disorder (OCD) as a humanitarian device exemption (HDE H050003, 2009) and a Conformité Européenne (CE mark, 2009) was obtained by Medtronic Inc.. Reimbursement became available in several EU countries. Evidence for safety and efficacy of DBS for treatment refractory OCD is increasing.
​
After 21 years of basic research and clinical trials, H. Wu et al. Molecular Psychiatry published the reasons why electrical stimulation for otherwise treatment refractory OCD using a multipolar electrode implanted in the ventral anterior capsule region (including bed nucleus of stria terminalis and nucleus accumbens) represents an emerging, but not yet established therapy. The authors are convinced that the medical community and the general public should be informed about the statement made in this manuscript, written under the auspices of the WSSFN and endorsed by, amongst others, a series of psychiatrists – co-authors.
​
H. Wu et al. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD) : emerging or established therapy ?”, Molecular Psychiatry, 2020, (https://rdcu.be/b9E3q) published.
Philip L. Gildenberg, MD, PhD
1935-2020
Phil Gildenberg was born in March 1935 in Hazelton, PA. He attended Valley Forge Military Academy and was awarded a scholarship to the University of Pennsylvania, where he graduated with honors having majored in zoology. Dr. Gildenberg then received his MD from the Temple University School of Medicine in 1959. During medical school he came to know Ernest Spiegel and Henry Wycis, who in essence invented human stereotactic neurosurgery, and were on the faculty at Temple. He worked with them throughout his neurosurgical residency at Temple, and began working on his PhD there. After Dr. Spiegel retired, Dr. Gildenberg completed his PhD thesis as an NIH Post-Doctor Fellow with Prof. Rolf Hassler at the Max Planck Institute for Brain Research in Frankfurt. He then joined the Cleveland Clinic as a junior faculty member, and in 1972, at the age of 37, was recruited to be the founding Chief of Neurosurgery at the University of Arizona College of Medicine. In 1975, Dr. Gildenberg became the founding Chair of Neurosurgery at the University of Texas, Houston. In 1982 he created the Houston Stereotactic Center, and continued to practice until 2001.
Many of us knew Phil Gildenberg from his tireless work for the field of stereotactic and functional neurosurgery. He kept the candle burning through decades when the few practitioners were derided as being “needle docs”, and he played a key role in the development and dissemination of computer-aided technology that has made stereotaxis ubiquitous. Dr. Gildenberg edited our journal, Stereotactic and Functional Neurosurgery, from 1975 (when it was known as Applied Neurophysiology) through 2001. At first with Dr. Ronald Tasker, and in the second edition with Dr. Andres Lozano, he edited the Textbook of Stereotactic and Functional Neurosurgery. Dr. Gildenberg served as the President of the American and World Societies for Stereotactic and Functional Neurosurgery in the 1990s, when not many people were pursuing those titles. He was the record keeper, the wise counsel, and the cheerleader for organized stereotactic and functional neurosurgery for decades. There is a lectureship in his name at the Baylor College of Medicine, where he was Adjunct Professor of Neurosurgery for many years, and the Philip Gildenberg award given by the Congress of Neurological Surgeons each year for the best resident or fellow paper in functional neurosurgery.
If you were fortunate to know Phil Gildenberg personally, you saw what a wonderful mentor he was to young neurosurgeons from whom he had nothing to gain except his desire to support others who shared his interests, and the palpable pleasure he took in seeing others grow their careers. In this, and in all of his manifold activities, he partnered with his wife, Patricia Franklin, who also took an interest in the community of stereotactic neurosurgeons and shared Phil’s delight in promoting young colleagues.
Dr. Gildenberg developed Parkinson’s disease in 2011, but did not care to talk about it and certainly did not complain. He died on January 15, 2020, and Pat died of lung cancer four days later, a month after that diagnosis of which her husband was not aware. Many of us Phil Gildenberg him a debt that we can’t repay except by keeping his memory alive and inspiring others, as he did many times over, to succeed and excel as stereotactic and functional neurosurgeons.
Michael Schulder, MD
Dear WSSFN members,
​
This marks the last year of my editorship. It has been a great privilege and honor to have had the opportunity to serve in this capacity, and I am deeply appreciative of all the work, guidance and support all of you have given. Thank you. Your journal has evolved substantially over the years: it has successfully transitioned into the on-line digital era, raised its Impact Factor eight-fold, received and published manuscripts from all parts of the world, and become the official journal of the World, American, European, Indian, Japanese, Korean, Middle East, Russian, China and Latin American stereotactic societies. It has long been the archive of pioneering work in our field, and we are confident that the journal will reach only greater heights going forward.
We are delighted that Andres Lozano, MD, PhD, has agreed to take up the journal’s editorship and steward Stereotactic and Functional Neurosurgery into a new decade. The Chair of Neurosurgery at the University of Toronto, Andres has been a long-time editorial board member of Stereotactic and Functional Neurosurgery, former president of the WSSFN and the ASSFN, and the 2013 recipient of the Ronald Tasker Award given quadrennial by the WSSFN. He is intimately familiar with the journal and its constituencies, and brings further editorial experiences from his time as the editor-in-chief of the Textbook of Stereotactic and Functional Neurosurgery, as well as from positions on other journals’ editorial boards. His work has spanned clinical practice, research, and teaching with long-standing research projects dedicated to identifying and testing novel therapeutic applications for deep brain stimulation. With respect to the journal, in his own words, “We are witnessing a convergence of important advances in the understanding of normal and pathological brain structure and function. The journal is in a position to document and transmit these exciting developments and to serve as a forum for debate and discussion. In so doing, it will act as an accelerator for the creation and distribution of new knowledge and treatments in neurological and psychiatric disorders.”
We look forward to Karger’s continued collaboration on Stereotactic and Functional Neurosurgery and serving our stereotactic colleagues and societies through the journal.
​
With best regards,
David
David W. Roberts, MD
Editor-in-Chief
New Membership Categories
New membership categories have been announced by the WSSFN for retired, senior members, resident I fellow members as well as allied health professionals. Those qualifying for these new membership categories will be able to subscribe to our society journal, STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, for the reduced rate of $135 (U.S.) plus shipping and handling. Please contact the society secretaliat for more infonnation on these new categories.
We hope that you will take advantage of this great offer.
Board Meeting Minutes
Additional society minutes have been archieved. If you need any information on available meeting minutes please contact the society adminstrator Melody Dian.